Humanin
Humanin. Mitochondrial-derived peptide with cytoprotective and metabolic signaling roles.
How it works. Binds formyl peptide receptor-like 1 and IGFBP-3 to suppress apoptosis pathways and improve mitochondrial bioenergetics under stress.
What the research supports. 2 graded claims. Strongest: Neuroprotective signaling (preclinical).
Hormonal impact. Effects on Insulin sensitivity, IGFBP-3 signaling, Inflammatory cytokines.
Side effects and interactions. 0 medication interactions listed. Serious: Limited human data.
Stacking. Pairs well with MOTS-c. Avoid combining with Unsupervised long-term use.
Common forms. Available as Subcutaneous injection (research).
Community. Experiences from people who have tried Humanin. Anecdotes are not medical advice.
Humanin. Mitochondrial-derived peptide with cytoprotective and metabolic signaling roles.
What it is
Humanin is a small peptide encoded within the mitochondrial 16S rRNA gene, identified for its protective effects against Alzheimer-related neurotoxicity.
How it works
Binds formyl peptide receptor-like 1 and IGFBP-3 to suppress apoptosis pathways and improve mitochondrial bioenergetics under stress.
Pathways
- BAX inhibition (anti-apoptotic)
- IGFBP-3 binding
- Insulin sensitivity
Effects
- +Neuronal survival under stress supports
- +Mitochondrial bioenergetics optimizes
- ↑Insulin sensitivity (preclinical) increases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Hormonal impact
Side effects & interactions
Common side effects
- Injection-site reactions
Serious
- Limited human data
No notable medication interactions listed.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- MOTS-cComplementary mitochondrial signaling.
Avoid combining
- Unsupervised long-term useSafety profile not characterized.
Common forms
- Subcutaneous injection (research)
Discussion
Loading discussion…